Literature DB >> 11945027

Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production.

Heather R Cross1, Elizabeth Murphy, Roberto Bolli, Peipei Ping, Charles Steenbergen.   

Abstract

PKC epsilon is a PKC isoform that translocates during preconditioning and may mediate cardioprotection. To investigate whether PKC epsilon activation is cardioprotective, Langendorff-perfused hearts from wild-type (WT) mice and from mice expressing constitutively active mutant PKC epsilon were subjected to 20 min ischemia and 40 min reperfusion while(31)P NMR spectra were acquired. Pre-ischemic glycogen levels were similar in WT and PKC epsilon hearts. During ischemia, ATP fell less in PKC epsilon than in WT hearts. Ischemic intracellular pH, however, was similar in WT and PKC epsilon hearts. During reperfusion, recovery of contractile function and ATP were greater in PKC epsilon than WT hearts. In conclusion, expression of activated PKC epsilon protected hearts from post-ischemic energetic and contractile dysfunction, consistent with the proposed cardioprotective role of PKC epsilon. Protection occurred in the PKC epsilon hearts without attenuation of ischemic H(+) production, implying that, at least in this ischemic model, reduced acidification during ischemia is not necessary for cardioprotection. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945027     DOI: 10.1006/jmcc.2001.1518

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  23 in total

1.  Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.

Authors:  Cecilia Giulivi; Catherine Ross-Inta; Alicja Omanska-Klusek; Eleonora Napoli; Danielle Sakaguchi; Genaro Barrientos; Paul D Allen; Isaac N Pessah
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

Review 2.  Proteomic technologies in the study of kinases: novel tools for the investigation of PKC in the heart.

Authors:  G Agnetti; L A Kane; C Guarnieri; C M Caldarera; J E Van Eyk
Journal:  Pharmacol Res       Date:  2007-05-03       Impact factor: 7.658

3.  High glucose protects embryonic cardiac cells against simulated ischemia.

Authors:  Vassiliki Malliopoulou; Christodoulos Xinaris; Iordanis Mourouzis; Alexandros D Cokkinos; Nikolaos Katsilambros; Constantinos Pantos; Elissavet Kardami; Dennis V Cokkinos
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

4.  The lipidated connexin mimetic peptide SRPTEKT-Hdc is a potent inhibitor of Cx43 channels with specificity for the pS368 phospho-isoform.

Authors:  Maura L Cotter; Scott Boitano; Paul D Lampe; Joell L Solan; Josef Vagner; Jose F Ek-Vitorin; Janis M Burt
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

5.  Perfused murine heart optical transmission spectroscopy using optical catheter and integrating sphere: Effects of ischemia/reperfusion.

Authors:  Tyler M Bauer; Abigail V Giles; Junhui Sun; Armel Femnou; Raul Covian; Elizabeth Murphy; Robert S Balaban
Journal:  Anal Biochem       Date:  2019-09-17       Impact factor: 3.365

6.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

7.  Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.

Authors:  Rui F D S Mesquita; Margaret A Paul; Aida Valmaseda; Asvi Francois; Rita Jabr; Shahzia Anjum; Michael S Marber; Vishwanie Budhram-Mahadeo; Richard J Heads
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

8.  Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.

Authors:  Samantha J Clarke; Igor Khaliulin; Manika Das; Joanne E Parker; Kate J Heesom; Andrew P Halestrap
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

9.  Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion.

Authors:  Eric N Churchill; Julio C Ferreira; Patricia C Brum; Luke I Szweda; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2009-10-10       Impact factor: 13.081

10.  Renin Angiotensin system as a regulator of cell volume. Implications to myocardial ischemia.

Authors:  Walmor C De Mello
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.